Synthesis of the Pitstop Family of Clathrin Inhibitors
Overview
Authors
Affiliations
This protocol describes the synthesis of two classes of clathrin inhibitors, Pitstop 1 and Pitstop 2, along with two inactive analogs that can be used as negative controls (Pitstop inactive controls, Pitnot-2 and Pitnot-2-100). Pitstop-induced inhibition of clathrin TD function acutely interferes with clathrin-mediated endocytosis (CME), synaptic vesicle recycling and cellular entry of HIV, whereas clathrin-independent internalization pathways and secretory traffic proceed unperturbed; these reagents can, therefore, be used to investigate clathrin function, and they have potential pharmacological applications. Pitstop 1 is synthesized in two steps: sulfonation of 1,8-naphthalic anhydride and subsequent reaction with 4-amino(methyl)aniline. Pitnot-1 results from the reaction of 4-amino(methyl)aniline with commercially available 4-sulfo-1,8-naphthalic anhydride potassium salt. Reaction of 1-naphthalene sulfonyl chloride with pseudothiohydantoin followed by condensation with 4-bromobenzaldehyde yields Pitstop 2. The synthesis of the inactive control commences with the condensation of 4-bromobenzaldehyde with the rhodanine core. Thioketone methylation and displacement with 1-napthylamine affords the target compound. Although Pitstop 1-series compounds are not cell permeable, they can be used in biochemical assays or be introduced into cells via microinjection. The Pitstop 2-series compounds are cell permeable. The synthesis of these compounds does not require specialist equipment and can be completed in 3-4 d. Microwave irradiation can be used to reduce the synthesis time. The synthesis of the Pitstop 2 family is easily adaptable to enable the synthesis of related compounds such as Pitstop 2-100 and Pitnot-2-100. The procedures are also simple, efficient and amenable to scale-up, enabling cost-effective in-house synthesis for users of these inhibitor classes.
OBrien N, Gilbert J, McCluskey A, Sakoff J RSC Med Chem. 2024; 15(5):1686-1708.
PMID: 38784470 PMC: 11110758. DOI: 10.1039/d3md00600j.
Liashkovich I, Stefanello S, Vidyadharan R, Haufe G, Erofeev A, Gorelkin P Bioeng Transl Med. 2023; 8(4):e10425.
PMID: 37476059 PMC: 10354767. DOI: 10.1002/btm2.10425.
Receptor-Dependent Endocytosis Mediates α-Synuclein Oligomer Transport Into Red Blood Cells.
Li W, Hu J, Li X, Lu Z, Li X, Wang C Front Aging Neurosci. 2022; 14:899892.
PMID: 35669464 PMC: 9163663. DOI: 10.3389/fnagi.2022.899892.
Watanabe Y, Nihonyanagi H, Numano R, Shibata T, Takashima K, Kurita H Sensors (Basel). 2022; 22(7).
PMID: 35408109 PMC: 9003051. DOI: 10.3390/s22072494.
Jaramillo-Polanco J, Lopez-Lopez C, Yu Y, Neary E, Hegron A, Canals M J Neurosci. 2022; 42(16):3316-3328.
PMID: 35256532 PMC: 9034783. DOI: 10.1523/JNEUROSCI.2098-21.2022.